Int J Biol Sci
2022; 18(3):1051.
doi:10.7150/ijbs.69329 This issueCite
Erratum
TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum
You Wang1,2*, Zhicheng Zhou3*, Xinran Wang1,2*, Xuping Zhang4,5, Yansu Chen4,5, Jin Bai4,5✉, Wen Di1✉
1. Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China; 2. Shanghai Key Laboratory of Gynecologic Oncology, Focus Construction Subject of Shanghai Education Department, Shanghai; 3. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; 4. Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China; 5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China. *These authors contributed equally to this work.
✉ Corresponding authors: Wen Di, Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China. E-mail: diwen163com; Jin Bai, Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical University, 84 West Huaihai Road, Xuzhou, 221002, Jiangsu Province, China. E-mail: bjedu.cn.More
Citation:
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci 2022; 18(3):1051. doi:10.7150/ijbs.69329. https://www.ijbs.com/v18p1051.htm
Wang, Y., Zhou, Z., Wang, X., Zhang, X., Chen, Y., Bai, J., Di, W. (2022). TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. International Journal of Biological Sciences, 18(3), 1051. https://doi.org/10.7150/ijbs.69329.
ACS
Wang, Y.; Zhou, Z.; Wang, X.; Zhang, X.; Chen, Y.; Bai, J.; Di, W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int. J. Biol. Sci. 2022, 18 (3), 1051. DOI: 10.7150/ijbs.69329.
NLM
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci 2022; 18(3):1051. doi:10.7150/ijbs.69329. https://www.ijbs.com/v18p1051.htm
CSE
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. 2022. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci. 18(3):1051.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.